awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42000134-39C9720E-E00C-4E2E-ACF4-750C007F0A78
Q42000134-39C9720E-E00C-4E2E-ACF4-750C007F0A78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42000134-39C9720E-E00C-4E2E-ACF4-750C007F0A78
Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
P2860
Q42000134-39C9720E-E00C-4E2E-ACF4-750C007F0A78
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42000134-39C9720E-E00C-4E2E-ACF4-750C007F0A78
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
298b4957e800e025fc9083cc0df4793c239aaaa8
P2860
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies